ELMO/CED-12 Domain Containing 3 (ELMOD3) (C-Term) Peptide
-
- Target See all ELMOD3 products
- ELMOD3 (ELMO/CED-12 Domain Containing 3 (ELMOD3))
- Protein Region
- C-Term
- Origin
- Human
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- FRLSRHHIQQ FPFCLMSVNI THIAIQALRE ECLSRECNRQ QKVIPVVNSF
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-ELMOD3 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- ELMOD3 (ELMO/CED-12 Domain Containing 3 (ELMOD3))
- Background
-
ELMOD3 lacks GTPase-activating protein (GAP) toward guanine nucleotide exchange factor ARL2.
Alias Symbols: FLJ21977, FLJ35601, LST3, MGC111036, RBED1, RBM29
Protein Size: 391 - Molecular Weight
- 44 kDa
- Gene ID
- 84173
- NCBI Accession
- NM_032213, NP_115589
- UniProt
- Q96FG2
-